查看购物车
  • Traditional Chinese
  • English
  • Japanese
欧洲下一代介入性心臟病学市场按产品类型、适应症类型、最终用户和地区分類的分析和预测（2025 年至 2035 年）
市场调查报告书
商品编码
1800746

欧洲下一代介入性心臟病学市场按产品类型、适应症类型、最终用户和地区分類的分析和预测（2025 年至 2035 年）

Europe Next-Generation Intervention Cardiology Market: Focus on Product Type, Indication Type, End User, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 87 Pages | 商品交期: 1-5个工作天内

价格

欧洲下一代介入性心臟病学市场规模预计将从 2024 年的 58.01 亿美元增长到 2035 年的 130.63 亿美元，在 2025-2035 年预测期内的复合年增长率为 7.66%。

新一代介入性心臟病学正在彻底改变欧洲的心臟护理，它采用先进的微创精准引导方法治疗心臟瓣膜疾病、冠状动脉疾病和结构性心臟缺陷。这个领域的一大特点是从传统的开胸手术转向更安全、更个人化的导管介入手术。欧洲医生正在整合机器人技术、人工智慧影像处理和尖端设备技术，以提高手术的安全性、准确性和效率。除了改善患者预后和缩短復原时间外，这项发展还支持欧洲的医疗保健目标，即增加获得最先进治疗、优化医院资源以及为老龄化人口提供高效的心血管解决方案。

主要市场统计数据
预测期 2025-2035
2025年评估 61.267亿美元
2035年的预测 130.63亿美元
复合年增长率 7.66%

市场介绍

随着医疗保健系统优先考虑以患者为中心的微创解决方案来治疗复杂的心血管疾病，欧洲新一代介入性心臟病学市场正经历快速转型。在欧洲，先进的导管介入手术正日益取代开胸手术，成为心血管疾病（包括冠状动脉疾病、结构性心臟异常和瓣膜疾病）发病率和死亡率的主要原因。这项转变源自于该地区致力于改善病患预后、减少住院时间和优化医疗资源。

新一代介入性心臟病学运用机器人技术、人工智慧影像处理、3D导航和先进的仪器技术，以提高手术的精确度、安全性和效率。欧洲各地的医疗机构正越来越多地采用药物涂层球囊、生物可吸收支架、经导管主动脉瓣置换术(TAVR) 和经导管二尖瓣瓣膜修復(TMVR) 等创新技术。混合导管室和门诊设施的建立进一步促进了这些最先进治疗的广泛应用，使患者更容易获得这些疗法。

包括欧盟医疗设备法规 (MDR) 在内的法律规范透过强制更高的安全标准和临床检验来规范产品核准。加之医疗保健投资的不断增加、人口老化以及医疗技术公司与学术机构之间强有力的研发合作，欧洲已成为下一代介入性心臟病学技术创新和应用的关键枢纽。

市场区隔

细分 1：按产品类型

  • 机器人
    • 机器人辅助经皮冠状动脉介入治疗（R-PCI）
    • 机器人辅助冠状动脉绕道手术手术（RA-CABG）
    • 机器人辅助二尖瓣置换术（RMVR）
    • 机器人辅助主动脉瓣置换术
  • 非机器人
    • IVUS
    • OCT
    • 其他干预措施
      • 支架
      • 导管
      • 导管导引线
      • PTCA球囊扩张术
      • 其他的

细分2：依适应症类型

  • 结构性心臟病
  • 冠状动脉疾病
  • 心臟瓣膜疾病
  • 周边动脉疾病
  • 先天性心臟疾病

第 3 部分：按最终用户

  • 医院和诊所
  • 心臟中心
  • 门诊手术中心

第四部分：按地区

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他的

欧洲下一代介入性心臟病学市场的趋势、驱动因素与挑战

趋势

  • 扩大采用下一代支架、球囊和导管的微创手术
  • 扩大经导管治疗（TAVR、TMVR 等）作为开胸心臟外科手术的替代方案
  • 整合机器人和影像引导系统可提高准确性并减少併发症
  • 药物涂层球囊、生物可吸收支架和新型支架材料的使用日益增多
  • 人工智慧、机器学习和 3D 影像在手术规划和即时指导中的应用日益增多
  • 欧洲门诊心臟护理中心和混合手术室成长强劲

驱动程式

  • 人口老化和生活方式导致的心血管疾病高发
  • 相较于传统手术，对创伤更小、恢復更快的治疗的需求日益增长
  • 欧洲医疗设备公司和研究机构支持的创新
  • 欧盟高阶心臟护理医疗政策与报销框架
  • 增加对数位医疗、远距心臟病学和远端患者监护的投资
  • 提高对冠状动脉疾病和结构性心臟疾病的认识和早期诊断

任务

  • 下一代介入设备和机器人系统的高成本限制了区域准入。
  • 欧盟成员国报销政策存在差异
  • 介入性心臟科医师采用新技术的学习曲线和训练要求
  • CE 标誌和欧盟 MDR 合规性的监管障碍导致产品上市延迟
  • 来自传统疗法和替代疗法的竞争
  • 小型医院混合导管室等基础设施有限

产品/创新策略：本报告深入洞察欧洲下一代介入性心臟病学的最新技术进步，使公司能够推动创新并开发满足市场需求的尖端产品。

成长/行销策略：透过提供全面的市场分析和识别关键的成长机会，公司能够获得制定有针对性的行销策略和有效扩大其市场占有率的知识。

竞争策略：报告包括全面的竞争格局分析，以了解欧洲下一代介入性心臟病学市场竞争对手的优势和劣势，并制定有效的策略以在市场上获得竞争优势。

监管与合规策略提供有关欧洲下一代介入心臟病学的法律规范、核准和行业指南的最新信息，使公司能够保持合规并加速新一代介入性心臟病学产品进入市场。

投资和业务扩大策略：透过分析市场趋势、资金筹措模式和合作机会，我们帮助公司做出明智的投资决策并确定业务成长的潜在併购机会。

主要市场参与企业和竞争对手的摘要

公司简介是根据从主要专家收集的意见以及对公司覆盖范围、产品系列和市场渗透率的分析而选择的。

该市场的一些知名公司包括：

  • B. Braun SE
  • Koninklijke Philips NV
  • Siemens Healthineers AG

目录

执行摘要

第一章：下一代介入性心臟病学市场：产业展望

  • 竞争格局
  • 下一代介入性心臟病学市场：诊断与管理
  • 冠状动脉介入治疗的进展
  • 冠状动脉介入的未来方向和新兴技术
  • 下一代介入性心臟病学市场的研发线产品
  • 监管状况
    • 欧洲

第二章 市场动态

  • 趋势
  • 市场动态

3. 下一代介入性心臟病学市场（按地区）价值，2024-2035 年

  • 区域摘要
  • 欧洲
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 其他的

第四章 竞争格局与公司概况

  • 公司简介
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • B. Braun SE

第五章调查方法

Product Code: BHL3206SS

This report can be delivered in 2 working days.

Introduction to Europe Next-Generation Intervention Cardiology Market

The Europe next-generation intervention cardiology market is projected to reach $13,063.0 million by 2035 from $5,800.1 million in 2024, growing at a CAGR of 7.66% during the forecast period 2025-2035. Next-generation interventional cardiology is revolutionizing cardiac treatment in Europe by using sophisticated, minimally invasive, precision-guided methods to treat valvular diseases, coronary artery disease, and structural heart defects. There has been a noticeable change in the area from traditional open heart surgery to safer, more individualized catheter-based procedures. Robotics, AI-enhanced imaging, and cutting-edge device technologies are being integrated by European doctors to increase procedure safety, accuracy, and efficiency. In addition to improving patient outcomes and shortening recovery periods, this development supports Europe's healthcare aims of increasing access to cutting-edge therapies, optimizing hospital resources, and providing efficient cardiovascular solutions to an aging population.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$6,126.7 Million
2035 Forecast$13,063.0 Million
CAGR7.66%

Market Introduction

The Europe Next-Generation Interventional Cardiology Market is undergoing a rapid transformation as healthcare systems prioritize minimally invasive, patient-centric solutions for managing complex cardiovascular diseases. Advanced catheter-based operations are increasingly replacing open heart surgeries as the primary source of morbidity and mortality in Europe due to cardiovascular illnesses such coronary artery disease, structural heart abnormalities, and valvular disorders. The region's focus on enhancing patient outcomes, cutting hospital stays, and making the most of healthcare resources is what is causing this change.

Robotics, AI-powered imaging, 3D navigation, and advanced device technologies are all used in next-generation interventional cardiology to improve accuracy, safety, and procedural efficiency. Healthcare facilities throughout Europe are adopting innovations including drug-coated balloons, bioresorbable scaffolds, transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve repair (TMVR) at an increasing rate. The spread of these cutting-edge therapies is further supported by the establishment of hybrid cath laboratories and ambulatory facilities, which provide greater accessibility for patients.

Regulatory frameworks, including the EU MDR (Medical Device Regulation), are shaping product approvals by enforcing higher safety standards and clinical validation. Coupled with rising healthcare investments, an aging population, and strong R&D collaborations between medtech companies and academic institutions, Europe is positioned as a key hub for next-generation interventional cardiology innovation and adoption.

Market Segmentation

Segmentation 1: By Product Type

  • Robotics
    • Robotic-Assisted Percutaneous Coronary Intervention (R-PCI)
    • Robotic-Assisted Coronary Artery Bypass Grafting (RA-CABG)
    • Robotic Assisted Mitral Valve-Replacement (RMVR)
    • Robotic Assisted Aortic Valve Replacement
  • Non-Robotics
    • IVUS
    • OCT
    • Other Interventions
      • Stents
      • Catheters
      • Guidewires
      • PTCA Balloons
      • Others

Segmentation 2: By Indication Type

  • Structural Heart Disease
  • Coronary Heart Diseases
  • Valvular Heart Diseases
  • Peripheral Artery Diseases
  • Congenital Heart Diseases

Segmentation 3: By End User

  • Hospitals and Clinics
  • Cardiac Centers
  • Ambulatory Surgical Centers

Segmentation 4: By Region

  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe

Europe Next-Generation Intervention Cardiology Market Trends, Drivers and Challenges

Trends

  • Growing adoption of minimally invasive procedures using next-gen stents, balloons, and catheters.
  • Expansion of transcatheter therapies (e.g., TAVR, TMVR) as alternatives to open-heart surgery.
  • Integration of robotics and image-guided systems to enhance precision and reduce complications.
  • Rising use of drug-coated balloons, bioresorbable scaffolds, and novel stent materials.
  • Increasing application of AI, machine learning, and 3D imaging in procedure planning and real-time guidance.
  • Strong growth in ambulatory cardiac care centers and hybrid operating rooms across Europe.

Drivers

  • High prevalence of cardiovascular diseases due to aging populations and lifestyle factors.
  • Growing demand for less invasive, faster-recovery treatments compared to conventional surgery.
  • Technological innovation supported by European medical device companies and research institutions.
  • Supportive EU healthcare policies and reimbursement frameworks for advanced cardiac interventions.
  • Rising investments in digital health, telecardiology, and remote patient monitoring.
  • Increasing awareness and early diagnosis of coronary and structural heart diseases.

Challenges

  • High cost of next-gen interventional devices and robotic systems limiting access in some regions.
  • Variability in reimbursement policies across EU member states.
  • Steep learning curve and training requirements for interventional cardiologists adopting new technologies.
  • Regulatory hurdles for CE marking and EU MDR compliance delaying product launches.
  • Competition from conventional procedures and alternative therapies.
  • Limited availability of infrastructure such as hybrid cath labs in smaller hospitals.

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in Europe next-generation intervention cardiology, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses in Europe next-generation intervention cardiology and allowing them to strategize effectively to gain a competitive edge in the market.

Regulatory and Compliance Strategy: It provides updates on evolving regulatory frameworks, approvals, and industry guidelines specific to Europe next-generation intervention cardiology, ensuring organizations stay compliant and accelerate market entry for new next-generation intervention cardiology

Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • B. Braun SE
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG

Table of Contents

Executive Summary

Scope and Definition

1 Next-Generation Intervention Cardiology Market: Industry Outlook

  • 1.1 Competitive Landscape
    • 1.1.1 Business Strategies
      • 1.1.1.1 Product Developments in Next-Generation Intervention Cardiology Market
  • 1.2 Next-Generation Intervention Cardiology Market: Diagnosis and Management
  • 1.3 Advancements in Coronary Intervention
  • 1.4 Future Direction and Emerging Technologies in Coronary Interventions
  • 1.5 Pipeline Products in the Next-Generation Intervention Cardiology Market
  • 1.6 Regulatory Landscape
    • 1.6.1 Europe

2 Market Dynamics

  • 2.1 Trends
    • 2.1.1 Trends in the Next-Generation Intervention Cardiology Market
      • 2.1.1.1 Shift towards Minimally Invasive and Percutaneous Procedures Transforming Treatment Paradigms
      • 2.1.1.2 Integration of AI-Predictive Intelligence in Intervention Cardiology
        • 2.1.1.2.1 AI in Imaging, Lesion Assessment, and Diagnostics
  • 2.2 Market Dynamics
    • 2.2.1 Trends, Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 2.2.2 Market Drivers
      • 2.2.2.1 Rising Elderly Population, Driving Demand for Advanced Cardiac Interventions
        • 2.2.2.1.1 Cardiovascular Disease Burden in the Elderly
      • 2.2.2.2 Emergence of Robotic-Assisted Interventions- Enhancing Procedural Accuracy and Operator Control
    • 2.2.3 Market Restraints
      • 2.2.3.1 High Procedural Cost and Infrastructure Burden Limiting Broad Adoption
      • 2.2.3.2 Regulatory Complexity and Prolonged Approval Timelines Hindering Innovation
        • 2.2.3.2.1 Lengthy Approval Pathways for High-Risk Devices
        • 2.2.3.2.2 Lack of Harmonization across Geographies
        • 2.2.3.2.3 Regulatory Gaps for AI and Software-Driven Devices
    • 2.2.4 Market Opportunities
      • 2.2.4.1 Stent and Balloon Innovation Unlocking Next-Generation Use Cases
        • 2.2.4.1.1 Advancements in Drug-Coated Balloon Technologies
      • 2.2.4.2 Remote and Robotic-Enabled Expansion into Emerging Markets
        • 2.2.4.2.1 Bridging Access Gaps through Remote Robotics
    • 2.2.5 Market Challenges
      • 2.2.5.1 Data Standardization and Clinical Validation Gaps in AI-Driven Cardiology
      • 2.2.5.2 Safety and Clinical Validation Barriers for Next-Generation Vascular Implants

3 Next-Generation Intervention Cardiology Market (Region), Value ($million), 2024-2035

  • 3.1 Regional Summary
  • 3.2 Europe
    • 3.2.1 Regional Overview
    • 3.2.2 Driving Factors for Market Growth
    • 3.2.3 Factors Challenging the Market
    • 3.2.4 U.K.
    • 3.2.5 France
    • 3.2.6 Germany
    • 3.2.7 Italy
    • 3.2.8 Spain
    • 3.2.9 Rest-of-Europe

4 Competitive Landscape and Company Profiles

  • 4.1 Company Profiles
    • 4.1.1 Siemens Healthineers AG
      • 4.1.1.1 Overview
      • 4.1.1.2 Top Products/Product Portfolio
      • 4.1.1.3 Top Competitors
      • 4.1.1.4 Target Customers
      • 4.1.1.5 Strategic Positioning and Market Impact
      • 4.1.1.6 Analyst View
      • 4.1.1.7 Pipeline and Research Initiatives
    • 4.1.2 Koninklijke Philips N.V.
      • 4.1.2.1 Overview
      • 4.1.2.2 Top Products/Product Portfolio
      • 4.1.2.3 Top Competitors
      • 4.1.2.4 Target Customers
      • 4.1.2.5 Strategic Positioning and Market Impact
      • 4.1.2.6 Analyst View
      • 4.1.2.7 Pipeline and Research Initiatives
    • 4.1.3 B. Braun SE
      • 4.1.3.1 Overview
      • 4.1.3.2 Top Products/Product Portfolio
      • 4.1.3.3 Top Competitors
      • 4.1.3.4 Target Customers
      • 4.1.3.5 Strategic Positioning and Market Impact
      • 4.1.3.6 Analyst View
      • 4.1.3.7 Pipeline and Research Initiatives

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Inclusion and Exclusion
    • 5.1.4 Data Triangulation
  • 5.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Next-Generation Intervention Cardiology Market (by Scenario), $Million, 2024, 2028, and 2035
  • Figure 2: Europe Next-Generation Intervention Cardiology Market, 2024-2035
  • Figure 3: Europe Next-Generation Intervention Cardiology Market Snapshot
  • Figure 4: Next-Generation Intervention Cardiology Market, $Million, 2024 and 2035
  • Figure 5: Europe Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024, 2028, and 2035
  • Figure 6: Europe Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024, 2028, and 2035
  • Figure 7: Europe Next-Generation Intervention Cardiology Market (by End User), $Million, 2024, 2028, and 2035
  • Figure 8: Next-Generation Intervention Cardiology Market Segmentation
  • Figure 9: Cardiovascular Disease Statistics
  • Figure 10: Inclusion and Exclusion Criteria for Europe Next-Generation Intervention Cardiology Market
  • Figure 11: Data Triangulation
  • Figure 12: Top-Down and Bottom-Up Approach
  • Figure 13: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Pipeline Products in Next-Generation Intervention Cardiology Market
  • Table 3: Next-Generation Intervention Cardiology Market (by Region), $Million, 2024-2035
  • Table 4: Europe Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 5: Europe Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 6: Europe Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 7: Europe Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 8: Europe Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 9: Europe Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 10: Europe Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 11: U.K. Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 12: U.K. Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 13: U.K. Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 14: U.K. Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 15: U.K. Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 16: U.K. Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 17: U.K. Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 18: France Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 19: France Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 20: France Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 21: France Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 22: France Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 23: France Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 24: France Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 25: Germany Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 26: Germany Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 27: Germany Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 28: Germany Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 29: Germany Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 30: Germany Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 31: Germany Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 32: Italy Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 33: Italy Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 34: Italy Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 35: Italy Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 36: Italy Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 37: Italy Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 38: Italy Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 39: Spain Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 40: Spain Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 41: Spain Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 42: Spain Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 43: Spain Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 44: Spain Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 45: Spain Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035
  • Table 46: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Product Type), $Million, 2024-2035
  • Table 47: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Robotics), $Million, 2024-2035
  • Table 48: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Non-Robotics), $Million, 2024-2035
  • Table 49: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Other Interventions), $Million, 2024-2035
  • Table 50: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Stents Type), $Million, 2024-2035
  • Table 51: Rest-of-Europe Next-Generation Intervention Cardiology Market (by Indication Type), $Million, 2024-2035
  • Table 52: Rest-of-Europe Next-Generation Intervention Cardiology Market (by End User), $Million, 2024-2035